The authors indicate relevance to "neurological pathologies such as Parkinson's disease, Alzheimer's disease, addiction, epilepsy and autism spectrum disorders."
Mejia M, Heghinian MD, Marí F, Godenschwege TA. New Tools for Targeted Disruption of Cholinergic Synaptic Transmission in Drosophila melanogaster. PLoS One. 2013 May 30;8(5):e64685. PMID: 23737994; PMCID: PMC3667824.